Sexual Vitality Addressed At Its Neurological Root.
- PT-141 · Bremelanotide
- PT-141 FDA-approved for women · Vyleesi®
- Discreet · Clinical · Confidential
Intimacy Is a Dimension of Health. Treat It Clinically.
Melanocortin Receptor Agonist · CNS-Acting
PT-141
Bremelanotide · Vyleesi® · FDA-Approved for HSDD in Premenopausal Women
PT-141 (bremelanotide) is FDA-approved as Vyleesi® for HSDD in premenopausal women, prescribed only after consultation. Other uses have not been reviewed or approved by FDA and are discussed only at consultation.
Mechanism: Activates MC3R and MC4R receptors in the hypothalamus · Influences neurological pathways governing sexual motivation and arousal · Distinct from vascular mechanism of PDE5 inhibitors.
- FDA-approved for HSDD in premenopausal women (Vyleesi®). Other uses have not been reviewed or approved by FDA and are disclosed at consultation, with risks, alternatives, and evidence review.
Typical Administration
Subcutaneous injection · As needed, approximately 45 minutes before intended use · Low-dose daily protocol also available
Sexual Health Peptides · Ann Arbor
Handled With Clinical Precision & Complete Discretion.
Sexual health consultations at Arbour Longevity are thorough, confidential, and clinically grounded. We assess the full picture, including hormones, neurological factors, and their interaction, and recommend the protocol that is appropriate, evidence-supported, and fully disclosed. If you are searching locally, we also have a page on erectile dysfunction treatment in Ann Arbor.



.webp)

